durvalumab,tremelimumab
astrazeneca,pfizer
['imfinzi', 'nsclc', 'sclc', 'tremelimumab']
#news #media: #imfinzi and tremelimumab with #chemotherapy showed overall survival in stage iv #nsclc patients. #pharma #pharmaceutical #healthcare #globalhealth #esmo22 #esmo2022 #esmo #cancer #oncology #cancer #cancerresearch #cancertreatment #cancercare
iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma